Patent · US Active

LXR modulators with bicyclic core moiety

US12291523B2 · kind B2 · utility

0Cited by

5References

2Claims

0Family size

Assignee

OrsoBio, Inc. · US

Inventors

Christian Gege · Ehingen (Donau), DE
Olaf Kinzel · Heidelberg, DE
Eva Hambruch · Mannheim, DE
Manfred Birkel · Seeheim-Jugenheim, DE
Claus Kremoser · Heidelberg, DE
Ulrich Deuschle · Bammental, DE

Key dates

Filing date	Mar 5, 2024
Grant date	May 6, 2025
Priority date	—
Expiry date	Mar 5, 2044

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/05
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to bicyclic compounds (e.g. indoles) containing a sulfonyl moiety, which bind to the liver X receptor (LXRa and/or LXKJ3) and act preferably as inverse agonists of LXR.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.